Navigation Links
Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Date:10/17/2011

ship Deals 77

10 Depression Therapeutics - Appendix 88

10.1 Market Definitions 88

10.2 Abbreviations 88

10.3 Methodology 89

10.3.1 Coverage 89

10.3.2 Secondary Research 90

10.3.3 Forecasting 90

10.3.4 Primary Research 92

10.3.5 Expert Panel Validation 93

10.4 Contact Us 93

10.5 Disclaimer 93

10.6 Bibliography 93

List of Tables

Table 1: Stages of Depression 7

Table 2: Depression Therapeutics Market, Global, Revenue ($bn), 2005–2010 21

Table 3: Depression Therapeutics Market, Global, Forecast ($bn), 2010–2018 22

Table 4: Depression Therapeutics Market, The US, Revenue ($m), 2005–2010 23

Table 5: Depression Therapeutics Market, The US, Forecast ($m), 2010–2018 24

Table 6: Depression Therapeutics Market, France, Revenue ($m), 2005–2010 25

Table 7: Depression Therapeutics Market, France, Forecast ($m), 2010–2018 26

Table 8: Depression Therapeutics Market, Germany, Revenue ($m), 2005–2010 27

Table 9: Depression Therapeutics Market, Germany, Forecast ($m), 2010–2018 28

Table 10: Depression Therapeutics Market, Italy, Revenue ($m), 2005–2010 29

Table 11: Depression Therapeutics Market, Italy, Forecast ($m), 2010–2018 30

Table 12: Depression Therapeutics Market, Spain, Revenue ($m), 2005–2010 31

Table 13: Depression Therapeutics Market, Spain, Forecast ($m), 2010–2018 32

Table 14: Depression Therapeutics Market, The UK, Revenue ($m), 2005–2010 33

Table 15: Depression Therapeutics Market, The UK, Forecast ($m), 2010–2018 34

Table 16: Depression Therapeutics Market, Japan, Revenue ($m), 2005–2010 35

Table 17: Depression Therapeutics Market, Japan, Forecast ($m), 2010–2018 36

Table 18: SSRIs Approved for Depression 41

Table 19: Summary of Results for the Pr
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Phreesias Digital Depression Screening Improves Early Detection and Drives Better Healthcare Outcomes in Medical Practices
2. Potential Mechanism of Action Identified for the Treatment of Major Depression With Trigeminal Nerve Stimulation (TNS) - The USB Port to the Brain™
3. Reportlinker Adds Product Profiles: Depression - Next generation Vies for Second-Line Patients
4. Naurex Initiates Phase II Clinical Trial of Novel Antidepressant GLYX-13 in Treatment-Resistant Depression
5. Neuralstem Updates NSI-189 Major Depression Trial
6. Vanda Pharmaceuticals to Evaluate Tasimelteon in Major Depression
7. CeNeRx Initiates Phase II Trial of TriRima™ as Monotherapy in Treatment Resistant Depression
8. Neuralstem Receives FDA Approval to Commence Drug Trial for Major Depression
9. Omega-3 Supplements Show Promise in Alleviating Depression
10. The Welcome Back Awards Seeks Nominations to Honor Leaders in the Depression Community
11. Research Published in Science Translational Medicine Underscores Value of Depression Gene Therapy License Held by Neurologix
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... ALEXANDRIA, Va. , July 30, 2014 /PRNewswire-USNewswire/ ... of Managed Care Pharmacy (AMCP) last evening expressed ... developed by the Joint Commission of Pharmacy Practitioners ... other member organizations over a two-year period to ... process for pharmacists.  "Pharmacists are ...
(Date:7/30/2014)... 30, 2014 PuraMed BioScience ® , ... over-the-counter (OTC) medicinal and healthcare products, announced today ... name along with the name,s red and yellow ... trademarked name MigraPure ®  going forward. The ... homeopathic, natural migraine pain reliever will be reintroduced ...
(Date:7/30/2014)... -- Research and Markets has announced the addition of ... report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... a lower CAGR in developed countries; however, it is expected to ... , India , and Brazil ... of the hematology analyzers and reagents market is driven by factors ...
Breaking Medicine Technology:AMCP Endorses JCPP "Pharmacists' Patient Care Process" 2PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 2PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 3Hematology Analyzers & Reagents Market - Forecasts to 2019 2
... 13, 3010 Amgen (Nasdaq: AMGN ) ... evaluating XGEVA™ (denosumab) versus placebo in 1,432 men with ... study, demonstrated that XGEVA significantly improved median bone metastasis-free ... p=0.03) compared to placebo (primary endpoint), and significantly improved ...
... Fla., Dec. 13, 2010 The creators of the innovative Pill ... toys and a much needed medication management system to pediatric ... at Broward General, in Fort Lauderdale, Florida. ... will be onsite Wednesday, December 15, from 1-3 pm distributing ...
Cached Medicine Technology:XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer 2XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer 3XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer 4XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer 5XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer 6XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer 7Med Time Technology, Inc. Teams up with Give A Smile, Inc. to Provide Pill Timer™ Kits and Toys to Children and Parents at the Chris Evert Children's Hospital of Broward General 2
(Date:7/30/2014)... York, New York (PRWEB) July 30, 2014 ... from uncontrollable brain bleeding has filed a Xarelto lawsuit ... by the blood thinner, Bernstein Liebhard LLP reports. According ... Court for the District of Vermont on July 25th, ... days when he suffered an irreversible brain bleed that ...
(Date:7/30/2014)... 2014 Imprivata ® (NYSE: ... and secure communications solutions for the healthcare industry, ... the most widely selected single sign-on (SSO) solution ... electronic medical records (EMR) systems with a 51 ... percent in the last 12 months), according to ...
(Date:7/30/2014)... Visitors to our region recognize how special it ... protection. Bob Kiesendahl, one of the owners of Woodloch ... Conservancy for donations collected through participation in the Green ... fast, as visitors welcome the opportunity to invest in ... The Kiesendahl family has owned Woodloch Resort for multiple ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Hamilton ... opening of its new Carmel office on July 30th. ... will finally be moving to the state-of-the-art suite, located ... and innovative space will allow for one-on-one patient comfort, ... surgery experience. , Dr. Hamilton’s new office-suite will ...
(Date:7/30/2014)... (HealthDay News) -- Some obese people have a genetic ... in their brains when they see food, researchers report. ... triggers feelings of pleasure and gratification at the sight ... designed to prevent overeating, the scientists suggested. More ... typically caused by a combination of overeating, a ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuit Alleges Man’s Death from Uncontrollable Brain Bleeding Was Caused by Xarelto, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit Alleges Man’s Death from Uncontrollable Brain Bleeding Was Caused by Xarelto, Bernstein Liebhard LLP Reports 3Health News:Imprivata Achieves 51 Percent Single Sign-on Market Share Amongst U.S. Hospitals Using McKesson Paragon or Horizon EMR Systems, According to HIMSS Analytics 2Health News:Pocono Mountain Resort Guests Contribute Over $8500 to Protect Land in 6 Short Months 2Health News:Hamilton Facial Plastic Surgery Opens New Carmel Office 2Health News:Gene Mutation May Make Food More Tempting 2
... Health Advocate Christy Turlington Burns will speak at the ... Health meeting at the AAP National Conference & Exhibition ... ET. Ms. Turlington Burns is the founder of Every ... to increase public awareness of and support for improved ...
... developed by the Centers for Disease Control and ... Pediatrics (AAP), will be launched at the 2011 ... Oct. 15-17. "Autism Case Training -- ... on the fundamental components of identifying, diagnosing, and ...
... New research presented this week highlights the ability ... investigate publicly available genomic data to assess biological ... prospective cancer biomarkers for further validation. The unique ... not possible by other methods, from the massive ...
... onset breast tenderness after starting combination hormone therapy may ... women who don,t experience breast tenderness, a study by ... One reason for this may be that their breasts ... was much more pronounced after initiation of estrogen and ...
... Il. -- MRI scanning could become a powerful new ... according to Loyola University Health System cardiologist Binh An ... MRI study of patients who had recently begun taking ... cholesterol drugs significantly reduced the amount of cholesterol in ...
... 14 (HealthDay News) -- One in six cellphones in Britain ... coli, likely because so many people don,t wash their hands ... The findings also suggest that many people lie about their ... of Hygiene & Tropical Medicine and Queen Mary, University of ...
Cached Medicine News:Health News:CDC to launch new autism curriculum at AAP national conference & exhibition 2Health News:Drug safety, efficacy, and potential new cancer biomarker predicted by NextBio 2Health News:Drug safety, efficacy, and potential new cancer biomarker predicted by NextBio 3Health News:Breast tenderness in women getting combo hormone therapy associated with increase in breast density 2Health News:Breast tenderness in women getting combo hormone therapy associated with increase in breast density 3Health News:MRIs could become powerful tools for monitoring cholesteral therapy 2Health News:1 in 6 Cellphones in Britain Contaminated With 'Fecal Matter' 2
Inquire...
... with low electroendosmosis (EEO) ... DNA/RNA applications. If separated ... be used as substrates ... and restriction endonucleases, a ...
... NuSieve 3:1 Agarose is a molecular biology grade, ... for fine resolution of small DNA, RNA, and ... enhance the speed of gel processing and blotting. ... resolution of DNA fragments up to 1,000 bp, ...
... With a very high gel ... exclusion limit, Certified megabase agarose is ... FIGE applications. The gels remain easy ... as 0.3% and allow shorter run ...
Medicine Products: